Richard Gregory
Director/Board Member at CANBRIDGE PHARMACEUTICALS INC.
Richard Gregory active positions
Companies | Position | Start | End |
---|---|---|---|
CANBRIDGE PHARMACEUTICALS INC. | Director/Board Member | 2020-04-20 | - |
Independent Dir/Board Member | 2020-04-20 | - |
Career history of Richard Gregory
Former positions of Richard Gregory
Companies | Position | Start | End |
---|---|---|---|
PROMIS NEUROSCIENCES, INC. | Director/Board Member | 2016-10-17 | 2023-04-26 |
Independent Dir/Board Member | 2016-10-17 | 2023-04-26 | |
IMMUNOGEN, INC. | Chief Tech/Sci/R&D Officer | 2015-01-04 | 2019-08-29 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2002-12-31 | 2013-12-31 |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Director/Board Member | 2020-04-27 | - |
Chief Tech/Sci/R&D Officer | 2020-04-27 | - | |
Q32 BIO INC. | Director/Board Member | 2014-12-31 | - |
Independent Dir/Board Member | 2014-12-31 | - |
Training of Richard Gregory
University of Massachusetts | Doctorate Degree |
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Statistics
International
United States | 7 |
Canada | 2 |
China | 2 |
Operational
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Independent Dir/Board Member | 3 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
PROMIS NEUROSCIENCES, INC. | Health Technology |
CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
Private companies | 4 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
- Stock Market
- Insiders
- Richard Gregory
- Experience